Abstract: Streptococcus pneumoniae is an pathogenic and opportunistic Gram-positive bacteria that
vaccination programs, although these have led to selection of the serotypes for 48 which vaccination is not yet available [3] . Antibiotic treatments for pneumococcal 49 and other lethal bacterial pathogens have resulted in the selection of bacteria with 50 high levels of resistance (the so-called 'superbugs') to which there is an urgency to 51 finding treatments alternative to the classical use (and sometimes abuse) of 52 antibiotics [4] . Thus, it has been proposed that tackling pneumococcal diseases 53 should consider approaches different than antibiotic treatments [5] . Among the 54 several possible strategies, two of them seem to be relevant because there are some 55 examples that can be taken as proofs of principle amenable to further advances: i) 56 inhibitors of bacterial conjugation (COINs), and ii) bacterial Toxin-Antitoxin 57 systems (TAS) [5, 6] . 58
The first approach, employment of COINs, contemplates the use of molecules 59 that are able to inhibit horizontal gene transfer (HGT) of genetic elements 60 conferring antibiotic resistance, like plasmids, Integrative and Conjugative 61
Elements (ICEs) and other mobile elements. Among inhibitors of HGT, it has been 62 shown that unsaturated fatty acids act as effective COINs molecules [7, 8] . Inhibition 63 seems to be due to interference with the ATPase activity of the VirB11-type 64 proteins, which are integrants of the Type IV Secretion System [9] . 65
The second approach contemplates strategies like the exploitation of the toxin 66
proteins from the bacterial TAS as targets for drug discovery, especially of type II 67 (proteic) family. Pioneer work in Gerdes' laboratory showed that TAS are present in 68 the majority of prokaryotes, but they are absent in eukaryotes [10] , and because of 69 this, they are considered as attractive molecules to be used as antibacterials [11] [12] [13] . 70
In general, type II TAS are organized as operons of two genes, the antitoxin 71 preceding the toxin genes; whereas the toxin is a stable protein, the antitoxin is a 72 labile protein mostly because of its unfolded nature [14, 15] . During bacterial growth 73 under steady-state conditions, the toxin-antitoxin proteins generate a harmless 74 self-regulated complex. However, under stressful circumstances, the TAS are 75 triggered and the antitoxin, exposed to the environment, would be prone to 76 degradation by proteases, releasing the toxin to act as a poison to halt cell growth, a 77 circumstance that has been proposed to exploit as an antibacterial strategy [16] . The 78 most promising approach to the use of TAS as antibacterials is based on the finding 79 that short peptides can disrupt the rather strong interactions between the toxin and 80 the antitoxin, making it possible to use these peptides as true antibacterials [17, 18] . 81
However, this approach requires that the three-dimensional structure of the TA 82 protein-protein complex is known in order to design the proper peptides. 83
Discovery of novel antibacterials nowadays is less focussed in testing large 84 amounts of compounds or libraries than it used to be, and now drug discovery is 85 helped by the use of known structures of the target. Thus, molecular docking and 86 structure-based designs are the favourite methods of choice, when feasible, in 87 modern drug discovery [19, 20] and is insensitive to rifampicin; thus, addition of the drug will stop transcription 116 from any of the E. coli promoters, and only the T7 promoters will be active [30] . 117
The S. pneumoniae strain R6 is a noncapsulated derivative from the virulent 118 strain D39 [32] , and was used either for: i) isolation of total chromosomal DNA and 119 PCR-amplification of a DNA region encompassing the relBE operon to clone it in 120 the expression vector [29] , or ii) amplification of a 256-bp DNA fragment that 121 includes the promoter region, the transcription initiation site, and the 122 Shine-Dalgarno sequences of the relBE operon, when functional assays were 123 performed. The same pneumococcal strain harbouring plasmid pMV158 was used 124 to prepare purified plasmid DNA by two consecutive CsCl gradients as reported 125
[34]. Design and cloning the truncated gene mobMN199 encoding the relaxase 126 domain of the pMV158-encoded mobM gene have been detailed elsewhere [28] . 127
Similarly, cloning of the His-tagged pneumococcal relBE operon (formerly termed 128 relBE2Spn) has been reported previously [31] . 129 130
Bacterial Growth Conditions 131
Pneumococcal cells were grown in the semi-defined medium AGCH [36,37] 132 supplemented with sucrose, until middle exponential phase (2-3 x 10 8 cells/ml). 133
Cells were collected by centrifugation and treated as reported to prepare either total 134 chromosomal DNA [38] or purified plasmid DNA. E. coli cells were grown in M9 135 medium that was prepared 10x [39] and that was enriched with vitamin (riboflavin, 136 biotin, thiamine and pyridoxine at 10 µg/ml, final concentration) and amino acids 137 mixtures (except methionine) at 40 µg/ml, final concentration. Glucose (20 mM, 138 final concentration) was the carbon source used. When needed, methionine (50 139 µg/ml, final concentration) was added to this enriched minimal medium 140 (EMM+Met). To prepare uniform pre-inocula, cells harbouring plasmids were 141 inoculated into 25 ml of EMM-Met, incubated at 37ºC until mid exponential phase 142 (~5x10 7 cells/ml) and centrifuged, washed with the same medium and concentrated 143 ten times. Glycerol (10%) was added and, after further 10 min incubation at 37ºC, 20 144 µl aliquots were prepared and stored at -80ºC until further use. Growth was 145 followed by determination of the optical density at 600 nm (OD600) of the cultures. 146 147
Labelling Proteins with SeMet and Protein Purification 148
Pre-inocula (10 µl) from the frozen samples (above) were inoculated into 5 ml fresh 149
EMM+Met and incubated at 37ºC until OD600 reached ~0.9. Four ml of this culture 150 was then diluted into 400 ml of the same pre-warmed medium and incubation 151 resumed until these cultures reached the same OD600 (around 4.5 h). Then, cells 152 were collected by centrifugation, washed twice with EMM lacking methionine and 153 resuspended into the original amount (400 ml) of the same medium. To deplete the 154 pool of internal methionine, cells were further incubated 30 min, 37ºC. Then, the 155 culture was added to 3.6 l of pre-warmed EMM+SeMet (50 µg/ml), separated into 156 750-ml portions and incubation resumed at 37ºC. When the OD600 reached ~0.8, 157
IPTG (final concentration 1 mM) was added and incubation resumed 2 h more. 158
Then, rifampicin (dissolved in dimethylsulfoxide), final concentration 100 µg/ml 159 was added, and incubation continued 1.5 h more. Cells were harvested by 160 centrifugation and washed with buffer A (MobMN199) or buffer C (RelB-RelE) 161 (Table 2) . Purification protocols for the untagged MobMN199 [28] and of the 162
His-tagged RelB-RelE(His)6 complex [31] proteins are described in the Results 163 
Section. 164

Mass Spectra Analyses 167
Matrix-assisted laser desorption/ionization (MALDI) experiments were performed 168 on an Autoflex III MALDI-TOF-TOF instrument (Bruker Daltonics, Bremen, 169
Germany) equipped with a smart-beam laser to measure the time of flying (TOF). 170
The spectra were acquired using a laser power just above the ionization threshold. 171
Samples were analyzed in the positive ion detection and delayed extraction linear 172 mode. Typically, 1,000 laser shots were summed into a single mass spectrum. 173
External calibration was performed using standard proteins (Sigma) namely insulin 174 (5.8 kDa), cytochrome C (12.4 kDa), trypsinogen (23.9 kDa), carbonic anhydrase (29 175 kDa), and protein A (44.6 kDa). The spectra covered the range from 2,000 to 30,000 176
Da. 177 178
Functional Analyses of SeMet Proteins 179
Relaxation assays with unlabelled and SeMet-labelled MobMN199 were performed 180 by incubation of supercoiled purified pMV158 plasmid DNA (300 ng, 8 nM) with 181 480 nM protein in buffer A (Table 2) , to which 15 mM MnCl2 was added. Incubation 182 was at 30ºC, 20 min, and the reaction products were separated by electrophoresis on 183 1% agarose gels as reported [28, 40] . Cleavage of supercoiled (forms FI) by the 184 proteins generated relaxed forms (FII), and the percent reaction was calculated by 185 subtracting the amount of already nicked molecules (faint FII band in the untreated 186 samples most likely generated by mechanical shearing) from the FII-forms 187 generated by protein treatment. The values of relaxed molecules were ~65% for the 188 two unlabelled and native proteins. In the case of the RelB-RelE protein-protein 189 complex, functional assays were done by electrophoretic mobility shift assays residues harbouring the endonuclease-relaxase domain (MobMN199; Figure 1A ) 218 was designed, and the DNA region encoding this truncated protein was cloned into 219 an expression vector. Protein MobMN199 was, thus, the best candidate to achieve 220 the three-dimensional structure of the MobM-relaxase domain in complex with its 221 target DNA [28] . Prediction of the secondary structure of MobMN199 ( Figure 1B 
242
The predicted secondary structure of RelB (left) suggested the existence of an N-terminal β-strand that could be incorporated into a β-sheet by interaction with another RelB molecule to fold as a 244 dimer with a ribbon-helix-helix structure [23] . All Met residues are marked in red; note that due to 245 processing the M1 residue was always removed.
247
In the case of the pneumococcal RelB-RelE proteins, the genetic structure of the 248 intergenic region ( Figure 1C) showed that the ATG start codon of relE (encoding the 249 toxin) is placed three codons upstream of the termination (TAA) codon of relB 250 (encoding the antitoxin), a situation indicative of translational coupling of both 251 proteins. The operon was cloned into an expression vector that tags the C-terminus 252 of relE with six His residues. Concerning the secondary structure predictions of the 253 proteins ( Figure 1D ), RelB would start with a β-strand followed by three α-helices, a 254 situation that resembles a protein with a ribbon-helix-helix structure [23], whereas 255
RelE would appear to have a distribution of α-helices and β-strands indicative of a 256 more complex structure. Circular dichroism studied supported these predictions 257 [31] . Analytical ultracentrifugacion and native mass spectrometry experiments 258 indicated that the RelB-RelE complex appeared to be a heterohexamer composed by 259 four antitoxin and two toxin protomers [31] . However, this hypothesis must wait 260 until the three-dimensional structures of the RelB-RelE proteins are solved. 261 262
Purification of the SeMet-labelled proteins 263
Purification of the SeMet MobMN199 and SeMet RelB-RelE complex was done by 264 induction of E. coli strain B834(DE3) harbouring plasmid pMobMN199 or plasmid 265 pET28relBE, respectively. Cultures from the frozen inocula were diluted in EMM 266 medium and grown at 37ºC. At OD600 = 0.5, cells were induced with 1 mM IPTG, 267 was anomalous and due to their isoelectric points [31] .
294
The cell lysate containing SeMet-labelled MobMN199 protein was cleared by 295 centrifugation for 30 min, 9500 rpm, 4ºC, and the supernatant was treated with 296 0.2% (v/v) polyethyleneimine (Sigma) to precipitate nucleic acids. Proteins in the 297 supernatant were precipitated at 70% (w/v) ammonium sulphate saturation. The 298 proteins in the precipitate were collected by centrifugation dissolved in Buffer A 299 (Figure 2A) . After dialysis against the same buffer, the sample was loaded onto a 300 100-ml heparin-agarose (BioRad) column (flow rate of 50 ml/h). After washing with 301 5-column volumes of the same buffer, a 400-ml 0.3-0.8 M NaCl gradient was 302 applied to elute the proteins retained. Fractions were analyzed by 15% 303 SDS-Tris-glycine polyacrylamide gel electrophoresis (SDS-PAGE) followed by 304 staining with Bio-safe Coomassie (BioRad Laboratories) ( Figure 2B ). Fractions 305 containing the peak of MobMN199 were pooled, dialysed against Buffer A 306 containing 500 mM NaCl, and concentrated by filtering through 3 kDa cut-off 307 membranes (Pall) until the sample volume reached 1 ml. The protein sample was 308 next automatically injected at 0.5 ml/min onto a HiLoad Superdex 200 gel-filtration 309 column (Amersham) and subjected to fast-pressure liquid chromatography (FPLC; 310 Biologic DuoFlow from BioRad). Fractions containing pure MobMN199 protein 311 (>98%) were pooled and concentrated until the final concentration was 5 mg/ml 312 protein ( Figure 2C) . 313
In the case of SeMet RelB-RelE, the cell lysate was cleared by centrifugation, 314 30 min, 9500 rpm, 4ºC, and the supernatant was loaded onto a nickel column 315 (His-select Nickel Affinity Gel, Sigma). After washing with buffer C, proteins were 316 eluted in the same buffer supplemented with 250 mM imidazol. Fractions were 317 analyzed by gel SDS-PAGE on 16% SDS-Tricine, and proteins were detected by 318 staining with Coomassie Brilliant blue R-250 (Bio-Rad Laboratories). Fractions 319 containing the peaks of the desired proteins were pooled, dialyzed against buffer S 320 and applied to a gel filtration column (Superdex 200 XK16/60 column, Amersham 321 Pharmacia Biotech). Fractions were analyzed by gel electrophoresis (Figure 2D ), 322
and we found that the RelE(His)6 protein exhibited an anomalous migration 323 (Mr~18000) higher than the theoretical value (Mr~11500). This is probably due to 324 the high isoelectric point of RelE (pI = 10.27) that makes the protein not to achieve auniform negative charge. Fractions containing the desired proteins were pooled 326 and concentrated by filtration through 3 kDa cut-off filters (Pall). The purified 327
proteins were stored at -80ºC where they remained active for at least one year. 328 329
MALDI-TOF Molecular Weight Determinations 330
To assess the degree of SeMet labelling of the pneumococcal proteins, we 331 determined the molecular weight of the unlabelled and labelled proteins by 332 employment of mass spectra experiments. The results are depicted in Figure 3 and 333 they are summarized in Table 3 . MALDI-TOF spectra of MobMN199 unlabelled 334 ( Figure 3A) or SeMet-labelled ( Figure 3B) showed the existence of a major peak 335 exhibiting molecular weights of 23,128.1 Da and 23,551.3 Da, respectively. The 336 difference between both values was of 423.2 Da, which is consistent with the 337 calculated theoretical value of MobMN199 protomers in which all the 9 Met 338 residues (Met1 was processed) were substituted by SeMet ones. Thus, the efficiency 339 of labelling was of 100%. 340
In the case of RelB proteins, unlabelled or labelled, two major peaks were 341 detected, the main one corresponding to RelB lacking M1, and a minor one 342 pertaining to the full RelB ( Figure 3C ). A similar finding was observed for RelE, but 343 in this case the main peak corresponded to the protein lacking the first three 344 residues (M1, N2, and N3), whereas the second minor peak could be assigned to the 345 entire RelE ( Figure 3D) . Again, the efficiency of labelling was of 100%. 346 
356
Functional Assays 367
To determine whether the SeMet-labelled proteins retained full activity, their 368 interactions with substrate DNA were assayed. As stated above, MobMN199 369 harbours the relaxase domain of the parental protein [28] and thus, the truncated 370 version is able to relax supercoiled cognate DNA as efficiently as the full-length 371
MobM. We tested the activity of the SeMet-MobMN199 on CsCl-purified pMV158 372 DNA under standard conditions (Methods and Figure 4A Table  375 2) containing 15 mM MnCl2 (final concentration). After 20 min incubation at 30ºC, 376 the reaction products were separated by electrophoresis on 1% agarose gels and 377 stained with ethidium bromide. The results showed that the amount of forms FII 378 (relaxed DNA molecules) generated by both proteins was roughly the same, an 379 amount of 65% of relaxed FII forms derived from the supercoiled FI substrate, 380 indicating that the cleavage reaction mediated by MobM ( Figure 4B ) was 381 independent on whether the protein has its Met residues substituted or not by 382 proteins. This region contains two palindromic sequences (PS1 and PS2) that are postulated to be the 401 target of the RelBE complex [31] .
403
In the case of the RelB-RelE pneumococcal protein complex, the antitoxin RelB 404 has a moderate DNA-binding affinity that is augmented by the toxin RelE, which 405 acts as a co-repressor of their own synthesis [29, 31] . The DNA-binding ability of the 406 double-stranded 256-bp fragment containing the RelB-RelE target (palindromes PS1 408 and PS2 in Figure 4D ; [31] ). The results showed that the free DNA ( Figure 4C , lane 409 1) molecules were progressively retarded into protein-DNA complexes that 410 increased with the protein concentrations used; the increase of retarded bands was 411 nearly in the same proportion independently whether the proteins were unlabelled 412 (lanes 2-4) or labelled with SeMet (lanes 5-7) . 413 414 
Conclusions
